Dr. Fumiaki Kobayashi is the president of CTD inc. Prior to founding CTD inc., in 2010, he belonged to the PMDEC (The Pharamceutical and Medical Device Evaluation Center) from 1997 to 2000, the OPSR (Organization for Pharmaceutical Safety and Research) from 2000 to 2002, the MHLW from 2002 to 2003. During these periods, he mainly engaged to evaluate and consult for new drugs. After, he joined the JMACCT (The Japan Medical Association Center for Clinical Trials) to create and operate IIT (Investigator Initiate Clinical Trials) and to lead the organization from 2004 to 2010.

Dr. Haruko Yamamoto, a specialist of neurology, is now the Director of the Dept. of Data Science at the National Cerebral and Cardiovascular Center (NCVC). After leading the academic research organization at NCVC for more than ten years, while worked as a specialist in cerebrovascular diseases, she was appointed as the Chief Medical Officer/ Associate Executive Director at the Pharmaceutical and Medical Devices Agency. She also has led several investigator-initiated clinical studies evaluating new drugs and high-risk medical devices. She served as a member of the DIA Advisory Council of Japan for four years, and is a member of program committee of the Medical Device Symposium. Dr. Yamamoto holds a PhD in medicine from Osaka University.